Talking Rheumatology Research
Discover the latest research from Rheumatology, Rheumatology Advances in Practice, and beyond.
Podcasting since 2022 • 51 episodes
Talking Rheumatology Research
Latest Episodes
Ep 51. Infliximab vs interferon-α in the treatment of Behçet’s syndrome: clinical data from the BIO-BEHÇET’S randomized controlled trial
In this episode, recorded live at BSR25, Professor Robert J Moots joins Professor Ernest Choy to discuss their article reporting on a randomized, controlled, head-to-head clinical trial comparing the two most frequently used biologics in active...
•
Episode 51
•
8:06
Ep 50. Modifiable risk factors and therapeutic targets in polymyalgia rheumatica
How can we identify modifiable risk factors and new therapeutic targets in polymyalgia rheumatica?In this episode, recorded live at BSR25, Prof Ernest Choy and Dr Steven Zhao discuss Steven's genome-wide meta-analysis and Mendelia...
•
Episode 50
•
9:22
Ep 49. Improving time to diagnosis in axial spondyloarthritis
How can we improve time from symptom onset to axSpA diagnosis?In this episode, Dr Fabian Proft talks to Dr Antoni Chan about his fantastic work to reduce time to diagnosis in axial spondyloarthritis (axSpA) using an integrated ref...
•
Episode 49
•
10:45
Ep 48. Deciphering difficult-to-treat psoriatic arthritis
Should there be distinct definitions for difficult-to-treat and complex-to-manage psoriatic arthritis?In this episode of Talking Rheumatology Research, Dr Fabian Proft and Dr Andre Ribeiro join Dr Ai Lyn Tan to discuss their work...
•
17:36
Ep 47. Relapse after cessation of weekly tocilizumab for giant cell arteritis
Dr. Vanessa Quick joins Dr. Ernest Choy to discuss her recent article on the impact of qwTCZ cessation on GCA patients. Looking at relapse rates and key risk factors, this discussion highlights the need for improving access to care ...
•
Episode 47
•
10:32